Results 1 to 10 of about 4,568 (155)

Clinical features and arrhythmic complications of patients with pediatric-onset arrhythmogenic right ventricular dysplasia [PDF]

Anatolian Journal of Cardiology, 2019
Objective: Arrhythmogenic right ventricular dysplasia (ARVD) is a myocardial genetic disease that occurs primarily in the right ventricle. Patients with ARVD may present with severe ventricular arrhythmias, syncope, and cardiac arrest.
Fatma Sevinç Şengül, Gülhan Tunca Şahin, Senem Özgür, Hasan Candaş Kafalı, Okan Akıncı, Alper Güzeltaş, Yakup Ergül   +6 more
doaj   +3 more sources

Implantable Cardioverter‐Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundArrhythmogenic right ventricular dysplasia/cardiomyopathy is characterized by ventricular arrhythmias and sudden cardiac death. Once the diagnosis is established, risk stratification to determine whether implantable cardioverter‐defibrillator ...
Gabriela M. Orgeron, Cynthia A. James, Anneline Te Riele, Crystal Tichnell, Brittney Murray, Aditya Bhonsale, Ihab R. Kamel, Stephan L. Zimmerman, Daniel P. Judge, Jane Crosson, Harikrishna Tandri, Hugh Calkins   +11 more
doaj   +3 more sources

Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Dysplasia [PDF]

Indian Pacing and Electrophysiology Journal, 2015
In this issue of 'EP Update' we summarize the recent literature on arrhythmogenic right ventricular dysplasia (ARVD). The articles have been hand picked and reviewed by the editors of IPEJ for the benefit of readers.
Johnson Francis, MD, DM, FACC, FRCP Edin, FRCP London, Narayanan Namboodiri   +1 more
doaj   +4 more sources

Desmosomal COP9 regulates proteome degradation in arrhythmogenic right ventricular dysplasia/cardiomyopathy. [PDF]

J Clin Invest, 2021
Dysregulated protein degradative pathways are increasingly recognized as mediators of human disease. This mechanism may have particular relevance to desmosomal proteins that play critical structural roles in both tissue architecture and cell‐cell ...
Liang Y, Lyon RC, Pellman J, Bradford WH, Lange S, Bogomolovas J, Dalton ND, Gu Y, Bobar M, Lee MH, Iwakuma T, Nigam V, Asimaki A, Scheinman M, Peterson KL, Sheikh F.   +15 more
europepmc   +2 more sources

Left ventricular fibro-fatty replacement in arrhythmogenic right ventricular dysplasia/cardiomyopathy: prevalence, patterns, and association with arrhythmias. [PDF]

J Cardiovasc Magn Reson, 2021
Background Left ventricular (LV) fibrofatty infiltration in arrhythmogenic right ventricular (RV) dysplasia/cardiomyopathy (ARVD/C) has been reported, however, detailed cardiovascular magnetic resonance (CMR) characteristics and association with outcomes
Zghaib T, Te Riele ASJM, James CA, Rastegar N, Murray B, Tichnell C, Halushka MK, Bluemke DA, Tandri H, Calkins H, Kamel IR, Zimmerman SL.   +11 more
europepmc   +2 more sources

Transesophageal and intracardiac ultrasound in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Two case reports. [PDF]

Medicine (Baltimore), 2020
Rationale: Two-dimensional echocardiography (2D echo) is a major tool for the diagnosis of Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). However 2D echo can skip regional localized anomalies of the right ventricular wall.
Cismaru G, Grosu A, Istratoaie S, Mada L, Ilea M, Gusetu G, Zdrenghea D, Pop D, Rosu R.   +8 more
europepmc   +2 more sources

Arrhythmogenic right ventricular cardiomyopathy/dysplasia [PDF]

Orphanet Journal of Rare Diseases, 2007
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a heart muscle disease clinically characterized by life-threatening ventricular arrhythmias. Its prevalence has been estimated to vary from 1:2,500 to 1:5,000.
Basso Cristina, Corrado Domenico, Thiene Gaetano   +2 more
doaj   +3 more sources

Physical exercise and arrhythmogenic right ventricular cardiomyopathy/dysplasia: An overview

Heart Views, 2022
Arrhythmogenic right ventricular cardiomyopathy/dysplasia is inherited cardiomyopathy that has a propensity for ventricular arrhythmia, ventricular dysfunction, and sudden cardiac death.
Rasha Kaddoura, Hassan Al-Tamimi
doaj   +2 more sources

Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia/cardiomyopathy patient. [PDF]

Europace, 2019
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a rare inherited heart muscle disease characterized by ventricular tachyarrhythmia, predominant right ventricular dysfunction, and sudden cardiac death.
Wang W, James CA, Calkins H.
europepmc   +2 more sources

Arrhythmogenic Right Ventricular Dysplasia in Neuromuscular Disorders [PDF]

Clinical Medicine Insights: Cardiology, 2016
Objectives Arrhythmogenic right ventricular dysplasia (ARVD) is a rare, genetic disorder predominantly affecting the right ventricle. There is increasing evidence that in some cases, ARVD is due to mutations in genes, which have also been implicated in ...
Josef Finsterer, Claudia Stöllberger
doaj   +3 more sources